Korea University Anam Hospital: Why Organ Transplant Patients Choose It

Korea University Anam Hospital (KUAH) in Seoul is not the largest hospital in Korea. It does not have the highest Newsweek ranking or the most beds. What it does have is one of the most distinguished organ transplant programs in the world, a program that has been running for over four decades, with survival outcomes that rival or exceed any transplant center in the United States, Europe, or Asia.

For international patients facing kidney failure, liver disease, or other conditions requiring transplantation, KUAH represents something rare: a top-tier transplant program at a fraction of US costs, in a hospital that has been accredited by the Joint Commission International (JCI) five consecutive times.

This article covers what makes KUAH’s transplant program exceptional, the specific programs available, costs, and what international patients should know before considering it.

KUAH’s Transplant History

Korea University Anam Hospital performed its first kidney transplant in 1969, making it one of the earliest transplant programs in Asia. The hospital’s transplant center has since completed over 4,000 organ transplants across kidney, liver, pancreas, and combined organ transplantation.

The hospital’s transplant program grew under the leadership of pioneering surgeons including Dr. Park Soon-Il, who has been instrumental in developing living donor transplant techniques that are now standard practice across Korean hospitals. Dr. Park’s work on ABO-incompatible kidney transplantation (transplanting kidneys between donors and recipients with different blood types) expanded the pool of viable donors significantly, a technique that has saved many lives when compatible donors were unavailable.

KUAH was also among the first Korean hospitals to develop full living donor liver transplantation programs, which is critical in a country where cadaveric organ availability is limited compared to Western nations.

Kidney Transplant Program

Survival Rates

KUAH’s kidney transplant outcomes are among the best documented globally. The hospital reports:

• 1-year graft survival rate: Over 98%
• 5-year graft survival rate: Over 95%
• 10-year graft survival rate: Over 90%

For context, the United States national average 5-year graft survival rate for deceased-donor kidney transplants is approximately 86%, and for living-donor transplants approximately 93% (per OPTN/SRTR data). KUAH’s living-donor kidney transplant outcomes consistently meet or exceed these benchmarks.

Types of Kidney Transplant Available

Living Donor Kidney Transplant: The most common type at KUAH. A healthy donor (typically a family member) donates one kidney. KUAH performs this laparoscopically, meaning the donor has a minimally invasive surgery with faster recovery (typically 2-3 weeks to return to normal activity).

ABO-Incompatible Kidney Transplant: For patients whose available donors have incompatible blood types. KUAH uses desensitization protocols (plasma exchange and immunosuppressive therapy) to make transplantation possible. This is a complex procedure that not all transplant centers worldwide offer routinely.

Deceased Donor Kidney Transplant: Available for patients registered on the Korean organ waiting list through the Korean Network for Organ Sharing (KONOS). International patients should be aware that wait times for deceased donor organs in Korea can be lengthy, and Korean citizens receive priority. Living donor transplant is the more practical path for most international patients.

Paired Kidney Exchange: When a patient has a willing but incompatible donor, KUAH can arrange paired exchanges, matching with another incompatible pair so each recipient receives a compatible kidney. This program expands transplant possibilities without requiring desensitization.

Post-Transplant Follow-Up

KUAH’s transplant follow-up protocol is rigorous. Patients typically stay in Korea for 2-4 weeks post-transplant for monitoring, with scheduled lab work at increasing intervals. After returning home, the hospital provides a detailed follow-up protocol that local nephrologists can continue, along with direct communication channels for the transplant team.

Liver Transplant Program

KUAH’s liver transplant program focuses primarily on living donor liver transplantation (LDLT), reflecting the broader Korean approach where cadaveric liver availability is limited.

Living Donor Liver Transplant

In LDLT, a healthy donor (usually a family member) donates a portion of their liver. The liver regenerates in both the donor and recipient within 6-8 weeks. KUAH’s surgical team performs this procedure using advanced techniques to minimize bile duct complications, which are the most common post-operative issue in LDLT.

Key outcomes at KUAH:
– 1-year patient survival rate: Over 90%
– Donor mortality rate: Less than 0.2% (comparable to the best centers worldwide)

Conditions Treated

KUAH’s liver transplant program treats:
– End-stage liver cirrhosis (alcohol-related, hepatitis B/C-related, autoimmune)
– Hepatocellular carcinoma (liver cancer) within transplant criteria
– Acute liver failure
– Metabolic liver diseases
– Biliary atresia (in pediatric cases)

Combined and Pancreas Transplant Programs

KUAH also performs:

• Simultaneous Pancreas-Kidney (SPK) Transplant: For Type 1 diabetes patients with kidney failure. This procedure can eliminate the need for both dialysis and insulin injections.
• Pancreas Transplant Alone: For select Type 1 diabetes patients with life-threatening hypoglycemic episodes.
• Combined Liver-Kidney Transplant: For patients with both liver and kidney failure.

These combined procedures require extraordinary surgical coordination. KUAH is one of a small number of Korean hospitals with the multi-disciplinary team to perform them.

Five-Time JCI Accreditation

The Joint Commission International (JCI) is the gold standard for international hospital accreditation. KUAH has earned JCI accreditation five consecutive times, a distinction shared by very few hospitals in Korea or globally.

JCI accreditation evaluates:
– Patient safety protocols
– Infection control standards
– Medication management
– Surgical safety (including pre-operative verification, time-outs, and site marking)
– Quality improvement processes
– Patient rights and informed consent

For transplant patients specifically, JCI accreditation means the hospital’s organ procurement, surgical, and post-operative protocols meet international standards. The accreditation process involves on-site inspections by international surveyors who review actual patient cases and observe procedures.

The Transplant Team

KUAH’s transplant center is staffed by a multi-disciplinary team that includes:

• Transplant surgeons (hepatobiliary and urologic)
• Transplant nephrologists and hepatologists
• Transplant anesthesiologists
• Transplant coordinators (including English-speaking international coordinators)
• Immunologists
• Pathologists specializing in transplant tissue analysis
• Psychologists (for donor and recipient evaluation)
• Nutritionists

The dedicated transplant anesthesiologists are a real differentiator. Transplant surgery requires specialized anesthetic management, particularly for liver transplants where blood loss can be significant and hemodynamic monitoring is critical. Not all hospitals have anesthesiologists with specific transplant training.

International Patient Support

KUAH operates a dedicated International Healthcare Center that provides:

Language Support: Full-time coordinators for English, Russian, Mongolian, Arabic, and Chinese. For transplant patients, this means all pre-operative consultations, informed consent discussions, surgical explanations, and post-operative instructions are communicated in the patient’s language.

Russian and Mongolian Specialization: KUAH has historically been one of the primary Korean hospitals serving patients from Russia, Mongolia, and Central Asian countries. The Russian-language coordination is particularly well-developed, with staff who understand the medical documentation requirements for Russian insurance and government-sponsored treatment programs.

Visa Assistance: The hospital provides documentation for Korea’s medical visa (C-3-3 for short-term treatment, G-1-10 for long-term treatment). Transplant patients typically require G-1-10 visas due to extended stays.

Accommodation Coordination: KUAH can arrange nearby serviced apartments or hospital guesthouses for patients and their families. Given that transplant recovery requires an extended stay (minimum 3-4 weeks), comfortable long-term accommodation near the hospital is essential.

Cost Comparison

Organ transplantation costs vary significantly by procedure type and complexity. Here are approximate ranges:

These costs include the pre-transplant evaluation, surgery, hospitalization (including ICU), initial post-operative care, and standard immunosuppressive medications during the hospital stay. They do not include:
– Donor evaluation and surgery (typically an additional $15,000-$25,000 for living donors)
– Extended hospital stay beyond the standard recovery period
– Long-term immunosuppressive medications (lifelong, typically $500-$2,000/month)
– Travel and accommodation

Even with all additional costs included, the total expense for a kidney transplant at KUAH (including donor surgery, travel, and 1 month of accommodation) typically runs $60,000 to $90,000. The same procedure in the US, even with insurance, often results in $50,000 to $100,000 in out-of-pocket costs after deductibles, co-pays, and uncovered expenses.

Health Checkup Packages at KUAH

KUAH also offers thorough health screening packages that international patients frequently combine with specialist consultations. These range from $490 for a basic screening to $5,330 for a premium executive checkup that includes advanced cancer screening (PET-CT), cardiac evaluation, endoscopy, and full blood panel.

For transplant candidates, the pre-transplant evaluation at KUAH is thorough and typically takes 3-5 days. It includes:
– Complete blood work and tissue typing (HLA)
– Cross-match testing
– Cardiac evaluation (echo, stress test)
– Pulmonary function tests
– Cancer screening
– Psychological evaluation
– Dental clearance

This evaluation can be scheduled through the International Healthcare Center before committing to surgery. Learn more about KUAH’s checkup packages.

Who Should Consider KUAH for Transplant

KUAH’s transplant program is particularly well-suited for:

Patients with living donors: The majority of KUAH’s transplants involve living donors. If you have a willing family member or friend, KUAH’s living donor protocols are world-class.

Patients needing ABO-incompatible transplant: If your only available donor has an incompatible blood type, KUAH’s desensitization protocols make transplantation viable.

Patients from Russia, Mongolia, or Central Asia: The established Russian and Mongolian language support, combined with institutional experience treating patients from these regions, reduces communication barriers that can be critical in transplant care.

Patients seeking a second opinion on transplant eligibility: Some patients told they are not transplant candidates in their home country may find that Korean transplant teams, with different experience and techniques, can offer options.

Patients who cannot afford US transplant costs: Even for patients with insurance, the out-of-pocket costs for transplant in the US can be devastating. KUAH offers the same quality of care at 75-85% lower cost.

What KUAH Is Not

Transparency matters. KUAH is not the right choice for every transplant patient:

• Deceased donor transplants for international patients involve long wait times and Korean citizens receive priority. If you need a deceased donor organ, the US or European systems may serve you better.
• Pediatric transplants are available but more limited in volume compared to specialized pediatric centers like Asan Medical Center.
• KUAH is a large general hospital, not a transplant-only institution. The transplant center is one department among many. If you want a hospital where transplant is the single primary focus, Seoul National University Hospital’s transplant center is larger in volume.

That said, for living donor kidney and liver transplants with international patient support, KUAH’s combination of outcomes, cost, JCI accreditation, and multilingual service is difficult to match.

Other Seoul Hospitals for Comparison

International transplant patients often evaluate multiple Korean hospitals. For reference:

• Severance Hospital (Yonsei): Also JCI-accredited, with a large transplant program and Newsweek #40 global ranking. Particularly strong in kidney transplant research.
• Seoul St. Mary’s Hospital: Catholic University’s flagship. World #5 in bone marrow transplant (different from solid organ transplant, but relevant for blood cancer patients). Newsweek #108 globally.
• Asan Medical Center: The highest-volume transplant center in Korea (not a partner hospital, but worth mentioning for completeness).

Read more about disease and treatment options in Korea.

Next Steps for Transplant Patients

If you or a family member are considering organ transplantation in Korea, the process begins with a remote evaluation. Send us your medical records (blood work, imaging, dialysis history, donor information if available), and we will coordinate a preliminary assessment with KUAH’s transplant team.

We handle every step: medical visa documentation, hospital scheduling, translation during all consultations, accommodation near the hospital, and airport transfers.

Talk to Our Team →